New Delhi, September 12: On Tuesday, the Union Health Ministry confirmed India’s first Mpox case. As per reports, the patient had visited a Mpox-infected nation recently.
The emergence of the virus in the country has raised significant concerns about the potential spread of this infection within the country. As the virus continues to infiltrate various regions, understanding the availability and effectiveness of vaccines becomes crucial in preventing further transmission and mitigating the impact of the outbreak.
In this article, we understand where India stands when it comes to containing this virus from spreading and whether the country has any vaccines to fight the virus.
Mpox Virus: What We Know About Monkeypox Infection
Mpox, previously known as monkeypox, is a viral disease that can cause a rash, fever, and swollen lymph nodes. It transmitted through close contact with an infected person or animal, or with contaminated materials. While Mpox is typically self-limiting and resolves within a few weeks. It can be severe in some individuals, especially those with weakened immune systems.
Mpox Outbreak: How World Is Battling The Virus
The current global Mpox outbreak, which began in early 2022, has seen a significant increase in cases worldwide. This outbreakcharacterized by a higher proportion of cases occurring among men who have sex with men, although anyone can contract the virus.
Mpox in India
The detection of Mpox cases in India marks a significant milestone in the global spread of the virus. As the country has a large population and a complex healthcare system, it is essential to implement effective measures to prevent further transmission and minimize the impact of the outbreak.
Availability of Mpox Vaccines
Several vaccines have developed to protect against monkeypox, including Jynneos (also known as Imvanity) and Bavarian Nordic’s MVA-BNJ. These vaccines primarily designed to protect against smallpox, but they have also shown to be effective against monkeypox.
Global Vaccine Distribution
The global supply of monkeypox vaccines has been limited, and there have been concerns about equitable distribution among countries. Many nations have prioritized vaccinating high-risk groups, such as healthcare workers and individuals at risk of exposure.
India’s Vaccine Preparedness
India has been working to secure a supply of monkeypox vaccines to address the growing threat. The government has taken steps to procure vaccines and develop domestic manufacturing capabilities. However, the availability of vaccines in India may still be limited, and it is important to prioritize vaccination for at-risk populations.
Read Also – Mpox Doesn’t Easily Spread Through Air: How It Transmits Among Humans
The detection of monkeypox cases in India highlights the urgent need for effective measures to prevent the spread of this virus. While vaccines are available, challenges related to supply, distribution, and public awareness must be addressed to ensure their optimal use.
Leave a comment